Zevenbergen Capital Investments’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-42,300	Closed	-$386K	–	106
2023 Q4	$386K	Buy	42,300 +2,000	+5%	+$18.2K	0.01%	92
2023 Q3	$222K	Hold	40,300	–	–	0.01%	99
2023 Q2	$344K	Hold	40,300	–	–	0.01%	97
2023 Q1	$370K	Buy	+40,300	New	+$370K	0.01%	96